| For: | Yoon JC, Yang CM, Song Y, Lee JM. Natural killer cells in hepatitis C: Current progress. World J Gastroenterol 2016; 22(4): 1449-1460 [PMID: 26819513 DOI: 10.3748/wjg.v22.i4.1449] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i4/1449.htm |
| Number | Citing Articles |
| 1 |
Hugo R. Rosen, Lucy Golden-Mason. Control of HCV Infection by Natural Killer Cells and Macrophages. Cold Spring Harbor Perspectives in Medicine 2020; 10(9) doi: 10.1101/cshperspect.a037101
|
| 2 |
M. Hentzien, A. Guihot, Doé de Maindreville, T. Tabary, V. Brodard, V. Vieillard, H. Adle-Biassette, F. Bani-Sadr. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient. Journal of NeuroVirology 2020; 26(4) doi: 10.1007/s13365-020-00848-x
|
| 3 |
Julia Pollmann, Alexander Rölle, Maike Hofmann, Adelheid Cerwenka. Hepatitis C Virus and Human Cytomegalovirus—Natural Killer Cell Subsets in Persistent Viral Infections. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00566
|
| 4 |
Chao Zhang, Xiao-mei Wang, Shu-ran Li, Trix Twelkmeyer, Wei-hong Wang, Sheng-yuan Zhang, Shu-feng Wang, Ji-zheng Chen, Xia Jin, Yu-zhang Wu, Xin-wen Chen, Sheng-dian Wang, Jun-qi Niu, Hai-rong Chen, Hong Tang. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09212-y
|
| 5 |
Roberto Giulio Romanelli, Gianfranco Vitiello, Stefano Gitto, Maria Grazia Giudizi, Roberta Biagiotti, Alessia Carraresi, Francesco Vizzutti, Giacomo Laffi, Fabio Almerigogna. Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study. International Journal of Immunopathology and Pharmacology 2020; 34 doi: 10.1177/2058738420929587
|
| 6 |
C. Fernández‐Ponce, M. Dominguez‐Villar, J. P. Muñoz‐Miranda, M. M. Arbulo‐Echevarria, R. Litrán, E. Aguado, F. García‐Cozar. Immune modulation by the hepatitis C virus core protein. Journal of Viral Hepatitis 2017; 24(5) doi: 10.1111/jvh.12675
|
| 7 |
Teresa Anita Mulaikal, Jean C. Emond. Liver Anesthesiology and Critical Care Medicine. 2018; doi: 10.1007/978-3-319-64298-7_1
|
| 8 |
Jose Ramón Vidal-Castiñeira, Antonio López-Vázquez, Paula Diaz-Bulnes, Susana Díaz-Coto, Leonardo Márquez-Kisinousky, Jesús Martínez-Borra, Carmen A. Navascues, Paloma Sanz-Cameno, Juan de la Vega, Aurora Astudillo, Manuel Rodríguez, Carlos López-Larrea. Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection. Journal of Molecular Medicine 2020; 98(9) doi: 10.1007/s00109-020-01948-1
|
| 9 |
Stephanie Jost, Jenny Ahn, Sarah Chen, Taylor Yoder, Kayitare Eunice Gikundiro, Esther Lee, Simon B Gressens, Kyle Kroll, Melissa Craemer, G Campbell Kaynor, Michelle Lifton, C Sabrina Tan. Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells. The Journal of Infectious Diseases 2024; 229(6) doi: 10.1093/infdis/jiad424
|
| 10 |
V. V. Tsukanov, M. A. Cherepnin, A. A. Savchenko, A. V. Vasyutin, E. V. Kasparov, A. G. Borisov, V. D. Belenyuk, Ju. L. Tonkikh. Subpopulation composition of blood NK cells in patients with hepatitis C with genotype 1 or 3. Meditsinskiy sovet = Medical Council 2023; (18) doi: 10.21518/ms2023-058
|
| 11 |
Sarah Vollmers, Annabelle Lobermeyer, Christian Körner. The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity. Cells 2021; 10(11) doi: 10.3390/cells10113108
|
| 12 |
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines 2020; 8(1) doi: 10.3390/vaccines8010090
|
| 13 |
Qingliang Wang, Xiaojie Li, Yaqiong Chen, Jiao Gong, Bo Hu. Classification and survival prediction in early‐stage cirrhosis by gene expression profiling. Journal of Viral Hepatitis 2023; 30(2) doi: 10.1111/jvh.13769
|
| 14 |
Pil Soo Sung, Jeong Won Jang. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications. International Journal of Molecular Sciences 2018; 19(11) doi: 10.3390/ijms19113648
|
| 15 |
Mengdi Qi, Mengmei Yang, Liangzi Xu, Chunli Ma, Pu Huang, Jing Sun, Jiandong Shi, Yunzhang Hu. Complete genome analysis identifies recombinant events and positive selection sites of hepatitis C virus from mainland China during 2010–2019. Virus Research 2021; 296 doi: 10.1016/j.virusres.2021.198354
|
| 16 |
Grace E. Cooper, Kristoffer Ostridge, Salim I. Khakoo, Tom M. A. Wilkinson, Karl J. Staples. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01671
|
| 17 |
Marc G. Ghany, Christopher M. Walker, Patrizia Farci. The Liver. 2020; doi: 10.1002/9781119436812.ch65
|
| 18 |
Madeline J. Lee, Catherine A. Blish. Defining the role of natural killer cells in COVID-19. Nature Immunology 2023; 24(10) doi: 10.1038/s41590-023-01560-8
|
| 19 |
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ali M. Bazzi, Wadha A. Alfouzan, Shahab A. Alsuliman, Fatimah A. Aldrazi, Shafiul Haque. Overview of hepatitis C infection, molecular biology, and new treatment. Journal of Infection and Public Health 2020; 13(5) doi: 10.1016/j.jiph.2019.11.015
|
| 20 |
Zepei Feng, Peng Huang, Jinwei Zhang, Xueshan Xia, A‐mei Zhang, Tian Zeng, Qiong Chen, Chuanlong Zhu, Weilong Tan, Yun Zhang, Ming Yue. KIR2DL4/HLA‐G polymorphisms were associated with HCV infection susceptibility among Chinese high‐risk population. Journal of Medical Virology 2023; 95(3) doi: 10.1002/jmv.28645
|
| 21 |
Chao Shen, Zhijun Ge, Chen Dong, Chunhui Wang, Jianguo Shao, Weihua Cai, Peng Huang, Haozhi Fan, Jun Li, Yun Zhang, Ming Yue. Genetic Variants in KIR/HLA-C Genes Are Associated With the Susceptibility to HCV Infection in a High-Risk Chinese Population. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.632353
|
| 22 |
Ayesha Obaid, Anam Naz, Aqsa Ikram, Faryal Mehwish Awan, Abida Raza, Jamil Ahmad, Amjad Ali. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27163-0
|
| 23 |
Julián Piñeiro Fernández, Kimberly A. Luddy, Cathal Harmon, Cliona O’Farrelly. Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174131
|
| 24 |
Elena Perpiñán, Sofía Pérez-Del-Pulgar, María-Carlota Londoño, Zoe Mariño, Concepción Bartres, Patricia González, Mireia García-López, Elisa Pose, Sabela Lens, Mala K. Maini, Xavier Forns, George Koutsoudakis. Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00129
|
| 25 |
Kamal Kajal, Venkata Ganesh, Sameer Sethi. Peri-operative Anesthetic Management in Liver Transplantation. 2023; doi: 10.1007/978-981-19-6045-1_2
|
| 26 |
Daniela Alejandra Rios, Paola Cecilia Casciato, María Soledad Caldirola, María Isabel Gaillard, Cecilia Giadans, Beatriz Ameigeiras, Elena Noemí De Matteo, María Victoria Preciado, Pamela Valva. Chronic Hepatitis C Pathogenesis: Immune Response in the Liver Microenvironment and Peripheral Compartment. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.712105
|
| 27 |
Chang Mo Yang, Joo Chun Yoon, Jeon Han Park, Jae Myun Lee, Ranjit Ray. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3. PLOS ONE 2017; 12(4) doi: 10.1371/journal.pone.0175793
|
| 28 |
Sergey M. Ivanov, Olga A. Tarasova, Vladimir V. Poroikov. Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1199482
|
| 29 |
Vladislav Vladimirovich Tsukanov, Andrei Anatolyevich Savchenko, Mikhail Aleksandrovich Cherepnin, Eduard Vilyamovich Kasparov, Elena Petrovna Tikhonova, Alexander Viktorovich Vasyutin, Julia Leongardovna Tonkikh, Anna Alexandrovna Anisimova, Vasily Dmitrievich Belenyuk, Alexandr Gennadyevich Borisov. Association of Blood NK Cell Phenotype with the Severity of Liver Fibrosis in Patients with Chronic Viral Hepatitis C with Genotype 1 or 3. Diagnostics 2024; 14(5) doi: 10.3390/diagnostics14050472
|
| 30 |
Joseph M. Cicchese, Stephanie Evans, Caitlin Hult, Louis R. Joslyn, Timothy Wessler, Jess A. Millar, Simeone Marino, Nicholas A. Cilfone, Joshua T. Mattila, Jennifer J. Linderman, Denise E. Kirschner. Dynamic balance of pro‐ and anti‐inflammatory signals controls disease and limits pathology. Immunological Reviews 2018; 285(1) doi: 10.1111/imr.12671
|
| 31 |
Mena Al-Ani, Noha Mousaad Elemam, Jennifer Elisabeth Hundt, Azzam A Maghazachi. <p>Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?</p>. Infection and Drug Resistance 2020; doi: 10.2147/IDR.S269797
|
| 32 |
Gaitan Fabrice Njiomegnie, Scott A. Read, Nicole Fewings, Jacob George, Fiona McKay, Golo Ahlenstiel. Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection. Journal of Clinical Medicine 2020; 9(4) doi: 10.3390/jcm9041030
|
| 33 |
Evgeniya V. Shmeleva, Francesco Colucci. Maternal natural killer cells at the intersection between reproduction and mucosal immunity. Mucosal Immunology 2021; 14(5) doi: 10.1038/s41385-020-00374-3
|
| 34 |
Supradip Dutta, Amlanjyoti Dhar, Meghamala Pande, Ankita Ghose, Moumita Majumdar, Sagnik Bakshi, Raina Das, Shreyasi Nath, Anwesha Ghosh, Provash Chandra Sadhukhan. Prediction of potential NS3-based T cell epitopes of hepatitis C virus by in-silico and in-vitro approach. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-49711-9
|
| 35 |
Julia Pollmann, Jana-Julia Götz, Daniel Rupp, Otto Strauss, Markus Granzin, Oliver Grünvogel, Pascal Mutz, Catharina Kramer, Felix Lasitschka, Volker Lohmann, Niklas K. Björkström, Robert Thimme, Ralf Bartenschlager, Adelheid Cerwenka. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis. Journal of Hepatology 2018; 68(3) doi: 10.1016/j.jhep.2017.10.021
|
| 36 |
Han-ji Jiang, Xiao-xiao Wang, Bi-fen Luo, Xu Cong, Qian Jin, Hong Qin, Hai-ying Zhang, Xiang-sha Kong, Lai Wei, Bo Feng. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients. Clinical and Experimental Medicine 2019; 19(3) doi: 10.1007/s10238-019-00564-9
|
| 37 |
Abdollah Jafarzadeh, Alma Naseri, Layla Shojaie, Maryam Nemati, Sara Jafarzadeh, Hossein Bannazadeh Baghi, Michael R Hamblin, Seyed Amirreza Akhlagh, Hamed Mirzaei. MicroRNA-155 and antiviral immune responses. International Immunopharmacology 2021; 101 doi: 10.1016/j.intimp.2021.108188
|
| 38 |
Agata Zientarska, Justyna Mikuła-Pietrasik, Mariusz Kaczmarek, Aleksandra Witkowska, Błażej Rozpłochowski, Arleta Kowala-Piaskowska, Krzysztof Książek, Jan Żeromski, Iwona Mozer-Lisewska. Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals. Central European Journal of Immunology 2021; 46(4) doi: 10.5114/ceji.2021.109846
|
| 39 |
Dora Maria Popescu, Dorin Nicolae Gheorghe, Flavia Nicolae, Lucian Paul Dragomir, Allma Pitru, Andrada Soanca, Cristina Florescu, Vasilica Toma, Liliana Georgeta Foia, Alexandra Livia Roman, Petra Surlin, Ion Rogoveanu. Chemokines Updates. Biochemistry 2023; 40 doi: 10.5772/intechopen.107318
|
| 40 |
Sarun Juengpanich, Liang Shi, Yasaman Iranmanesh, Jiang Chen, Zhenzhe Cheng, Aaron Kah-Jin Khoo, Long Pan, Yifan Wang, Xiujun Cai. The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review. Translational Oncology 2019; 12(8) doi: 10.1016/j.tranon.2019.04.021
|